These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 17590361)
1. Cell type dependent regulation of multidrug resistance-1 gene expression by AML1-ETO. Hines R; Boyapati A; Zhang DE Blood Cells Mol Dis; 2007; 39(3):297-306. PubMed ID: 17590361 [TBL] [Abstract][Full Text] [Related]
2. ETO, but not leukemogenic fusion protein AML1/ETO, augments RBP-Jkappa/SHARP-mediated repression of notch target genes. Salat D; Liefke R; Wiedenmann J; Borggrefe T; Oswald F Mol Cell Biol; 2008 May; 28(10):3502-12. PubMed ID: 18332109 [TBL] [Abstract][Full Text] [Related]
3. AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia. Jin W; Wu K; Li YZ; Yang WT; Zou B; Zhang F; Zhang J; Wang KK Oncogene; 2013 Apr; 32(15):1978-87. PubMed ID: 22641217 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia. Huang S; Jiang MM; Chen GF; Qian K; Gao HH; Guan W; Shi JL; Liu AQ; Liu J; Wang BH; Li YH; Yu L Chin Med J (Engl); 2016 Jun; 129(11):1355-62. PubMed ID: 27231175 [TBL] [Abstract][Full Text] [Related]
5. Multi-sites cleavage of leukemogenic AML1-ETO fusion protein by caspase-3 and its contribution to increased apoptotic sensitivity. Lu Y; Peng ZG; Yuan TT; Yin QQ; Xia L; Chen GQ Leukemia; 2008 Feb; 22(2):378-86. PubMed ID: 17989718 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of Bcl-2, CEBPA and p14(ARF) by the AML1-ETO oncoprotein contributing to growth arrest and differentiation block in the U937 cell line. Zhuang WY; Cen JN; Zhao Y; Chen ZX Oncol Rep; 2013 Jul; 30(1):185-92. PubMed ID: 23673926 [TBL] [Abstract][Full Text] [Related]
7. Leukemogenic AML1-ETO fusion protein increases carcinogen-DNA adduct formation with upregulated expression of cytochrome P450-1A1 gene. Xu M; Li D; Lu Y; Chen GQ Exp Hematol; 2007 Aug; 35(8):1249-55. PubMed ID: 17560011 [TBL] [Abstract][Full Text] [Related]
8. The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1. Frank RC; Sun X; Berguido FJ; Jakubowiak A; Nimer SD Oncogene; 1999 Mar; 18(9):1701-10. PubMed ID: 10208431 [TBL] [Abstract][Full Text] [Related]
9. RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis. Yan M; Ahn EY; Hiebert SW; Zhang DE Blood; 2009 Jan; 113(4):883-6. PubMed ID: 19036704 [TBL] [Abstract][Full Text] [Related]
10. AML1/ETO trans-activates c-KIT expression through the long range interaction between promoter and intronic enhancer. Tian Y; Wang G; Hu Q; Xiao X; Chen S J Cell Biochem; 2018 Apr; 119(4):3706-3715. PubMed ID: 29236325 [TBL] [Abstract][Full Text] [Related]
11. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Linggi B; Müller-Tidow C; van de Locht L; Hu M; Nip J; Serve H; Berdel WE; van der Reijden B; Quelle DE; Rowley JD; Cleveland J; Jansen JH; Pandolfi PP; Hiebert SW Nat Med; 2002 Jul; 8(7):743-50. PubMed ID: 12091906 [TBL] [Abstract][Full Text] [Related]
12. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis. Peterson LF; Lo MC; Okumura AJ; Zhang DE Blood Cells Mol Dis; 2007; 39(3):321-8. PubMed ID: 17692541 [TBL] [Abstract][Full Text] [Related]
13. [Influence of AML1 and AML1-ETO on transcriptional regulation of nucb2 gene]. Zou B; Jin W; Li J; Shi JT; Zhang J; Wang KK Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1482-6. PubMed ID: 20030931 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice. Kagiyama Y; Kitaura J; Togami K; Uchida T; Inoue D; Matsukawa T; Izawa K; Kawabata KC; Komeno Y; Oki T; Nakahara F; Sato K; Aburatani H; Kitamura T Int J Hematol; 2012 Nov; 96(5):638-48. PubMed ID: 23097187 [TBL] [Abstract][Full Text] [Related]
15. E protein silencing by the leukemogenic AML1-ETO fusion protein. Zhang J; Kalkum M; Yamamura S; Chait BT; Roeder RG Science; 2004 Aug; 305(5688):1286-9. PubMed ID: 15333839 [TBL] [Abstract][Full Text] [Related]
16. [Effect of AML1-ETO fusion protein on the expression of BCL-2]. Zhuang WY; Li ZY; Zhao Y; Cen JN; Zhuang WZ; Chen ZX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1394-8. PubMed ID: 24370018 [TBL] [Abstract][Full Text] [Related]
17. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia. Fu L; Huang W; Jing Y; Jiang M; Zhao Y; Shi J; Huang S; Xue X; Zhang Q; Tang J; Dou L; Wang L; Nervi C; Li Y; Yu L FEBS J; 2014 Feb; 281(4):1123-31. PubMed ID: 24314118 [TBL] [Abstract][Full Text] [Related]
18. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Frank R; Zhang J; Uchida H; Meyers S; Hiebert SW; Nimer SD Oncogene; 1995 Dec; 11(12):2667-74. PubMed ID: 8545124 [TBL] [Abstract][Full Text] [Related]
19. ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO. Lausen J; Liu S; Fliegauf M; Lübbert M; Werner MH Oncogene; 2006 Mar; 25(9):1349-57. PubMed ID: 16247445 [TBL] [Abstract][Full Text] [Related]
20. [Genomic distribution of AML1-ETO fusion protein binding sites]. He MM; Shi JT; Zhu XH; Jin W; Wang P; Zhang J; Wagn KK Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):553-8. PubMed ID: 20561400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]